Royal Bank of Canada set a €130.00 ($151.16) target price on Hannover Re (FRA:HNR1) in a report issued on Wednesday, April 3rd, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
HNR1 has been the topic of a number of other reports. Goldman Sachs Group set a €120.00 ($139.53) target price on Hannover Re and gave the stock a neutral rating in a report on Wednesday, February 27th. UBS Group set a €123.00 ($143.02) target price on Hannover Re and gave the stock a neutral rating in a report on Friday, February 1st. Credit Suisse Group set a €122.00 ($141.86) target price on Hannover Re and gave the stock a neutral rating in a report on Wednesday, February 6th. JPMorgan Chase & Co. set a €114.00 ($132.56) target price on Hannover Re and gave the stock a neutral rating in a report on Wednesday, January 9th. Finally, Barclays set a €109.00 ($126.74) target price on Hannover Re and gave the stock a sell rating in a report on Thursday, December 13th. Three research analysts have rated the stock with a sell rating and sixteen have assigned a hold rating to the company’s stock. The stock has a consensus rating of Hold and a consensus price target of €117.04 ($136.09).
Shares of HNR1 stock remained flat at $€135.00 ($156.98) on Wednesday. The stock had a trading volume of 147,084 shares. Hannover Re has a 52-week low of €94.75 ($110.17) and a 52-week high of €116.37 ($135.31).
Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Featured Story: Debt-To-Equity Ratio
Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.